3,716 results on '"Ludolph A. C."'
Search Results
2. Neuropeptide FF (NPFF)-positive nerve cells of the human cerebral cortex and white matter in controls, selected neurodegenerative diseases, and schizophrenia
3. Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients
4. AI-assisted automatic MRI-based tongue volume evaluation in motor neuron disease (MND)
5. Myelitis as a side effect of tofersen therapy in SOD1-associated ALS
6. Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin
7. Neurological manifestation of HEV infection: still a rare disease entity?
8. Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
9. Clinical and paraclinical features of first unprovoked seizures in the elderly
10. Structural parameters are superior to eigenvector centrality in detecting progressive supranuclear palsy with machine learning & multimodal MRI
11. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany
12. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers
13. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
14. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
15. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
16. The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
17. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
18. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis
19. Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
20. The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe
21. AI-assisted quantification of hypothalamic atrophy in amyotrophic lateral sclerosis by convolutional neural network-based automatic segmentation
22. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes
23. Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value
24. Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI
25. Mitochondrial genome study in blood of maternally inherited ALS cases
26. Impaired ATF3 signaling involves SNAP25 in SOD1 mutant ALS patients
27. Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: a clinicopathological study
28. Quality of life and depression in patients with amyotrophic lateral sclerosis – does the country of origin matter?
29. Integrative genetic analysis illuminates ALS heritability and identifies risk genes
30. Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis
31. Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis
32. Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
33. A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity
34. Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design
35. Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
36. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
37. Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study
38. Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex
39. Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease
40. Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum
41. Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients
42. ALS is imprinted in the chromatin accessibility of blood cells
43. Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cells
44. Hypothalamic atrophy in primary lateral sclerosis, assessed by convolutional neural network-based automatic segmentation.
45. Blood–CSF barrier integrity in amyotrophic lateral sclerosis.
46. Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1.
47. Involvement of cortico-efferent tracts in flail arm syndrome: a tract-of-interest-based DTI study
48. The spectrum and differential diagnosis of acquired ocular motor nerve palsies: a clinical study of 502 patients
49. Blood GFAP as an emerging biomarker in brain and spinal cord disorders
50. Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.